Abstract
Bacterial adaptive immunity hinges on CRISPR-Cas systems that provide DNA-encoded, RNA-mediated targeting of exogenous nucleic acids. A plethora of CRISPR molecular machines occur broadly in prokaryotic genomes, with a diversity of Cas nucleases that can be repurposed for various applications.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adaptive Immunity / genetics*
-
Animals
-
Bacteria / genetics
-
Bacteria / immunology
-
CRISPR-Cas Systems / genetics*
-
CRISPR-Cas Systems / immunology
-
DNA / genetics
-
Genetic Engineering / methods
-
Genetic Variation / genetics*
-
Genetic Variation / immunology
-
Humans
-
RNA Editing / genetics